Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2006-10-17
2006-10-17
Azpuru, Carlos A. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
Reexamination Certificate
active
07122201
ABSTRACT:
Compositions and methods are provided for reducing adverse reactions as a result of parenteral administration of certain phenothiazine derivatives such as promethazine, including promethazine hydrochloride. The active compound may be admixed with an effective amount of one or more non-ionic surfactants and at least one amino acid and/or one polyol prior to administration to an animal such as a mammal.
REFERENCES:
patent: 4071620 (1978-01-01), Sklar
patent: 4246894 (1981-01-01), Hamacher
patent: WO 96/11007 (1996-04-01), None
patent: WO 96 11007 (2000-01-01), None
Kuster, J., Increases in Creatine Kinase Activity after Intramuscular Injection of Various Drugs, Med. Welt., vol. 24, 1973, pp. 1328-1330.
“Promethazine Hydrochloride Injection,” The United States Pharmacopeia, USP24, Jan. 1, 2000, p. 1412, Rockville, MD, USA.
Kaczmarczyk, Franciszek et al., Chemical Abstracts Database Accession No. 73:7181 (XP-002215218), “Incompatibility in Compound Injections. I. Salting Out,” from ACTA Pol. Pharm., 1969, vol. 26(6), pp. 555-558.
Yalkowsky, Samuel H. et al., “In-Vitro Method for Detecting Precipitation of Parenteral Formulations After Injection,” Journal of Pharmaceutical Sciences, vol. 72, No. 9, Sep. 1983, pp. 1014-1017.
Med. Welt. 24, 1328-30, J. Kuster (1973).
Phenergan Injection (Wyeth-Ayerst), Physician's Desk Reference, 53 Edition, 1999.
Hager, et al., “Gangrene of the hand following intra-arterial injection,” Anest. Analg., 47(4):423-427, 1968.
Webb, et al., “Accidental arterial injection,” Am. J. Obstet. Gynecol., 101(3):365-371, 1968.
Paulate Virginia
Yu Jianwei
Yuen Pui-Ho
Azpuru Carlos A.
Baxter International Inc.
Jaconetty Kenneth E.
Mayo Michael C.
LandOfFree
Composition and method for reducing adverse interactions... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for reducing adverse interactions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for reducing adverse interactions... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3631126